Nektar, Verastem Among Healthcare Additions in Russell Microcap; Assertio, Sangamo Removed
TherapeuticsMD | 10-Q: Quarterly report
Express News | TherapeuticsMD Q1 EPS $(0.07) Up From $(0.24) YoY
Express News | TherapeuticsMD Inc - Continues to Evaluate a Variety of Strategic Alternatives
TherapeuticsMD 1Q Cont Ops Loss/Shr 7c >TXMD
Express News | TherapeuticsMD Q1 Operating Expenses USD 1.5 Million
Express News | TherapeuticsMD Announces First Quarter 2024 Financial Results
TherapeuticsMD: Evaluation of Strategic Alternatives Continues >TXMD
TherapeuticsMD 2023 Cont Ops Loss/Shr 74c >TXMD
Press Release: TherapeuticsMD Announces Full Year 2023 Financial Results
25 Countries With Highest Abortion Rates
A Look Into Healthcare Sector Value Stocks
TherapeuticsMD(TXMD.US) Officer Sells US$43,683.9 in Common Stocks
Stocks to Watch: Getty Images, TherapeuticsMD, Solid Biosciences
TherapeuticsMD Exploring Strategic Alternatives for Company
TherapeuticsMD Q3 EPS $(0.13) Misses $(0.05) Estimate
Therapeutics MD GAAP EPS of -$0.13
TherapeuticsMD: Hasn't Set Timetable for Completion of Exploration Process and Doesn't Intend to Disclose Further Developments Unless and Until It Is Determined That Disclosure Is Appropriate or Necessary >TXMD
TherapeuticsMD: Evaluating Strategic Alternatives That May Include an Acquisition, Merger, Other Business Combination, Sale of Assets, or Other Strategic Transactions >TXMD
TherapeuticsMD 3Q Loss/Shr 13c >TXMD